Glutamine and glutathione at ICU admission in relation to outcome. - Wikidata - awgldk - TriplyDB

Glutamine and glutathione at ICU admission in relation to outcome.

Glutamine and glutathione at ICU admission in relation to outcome.

http://www.wikidata.org/entity/Q35804639

about

Exogenous Glutamine in Respiratory Diseases: Myth or Reality?Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis A tracer bolus method for investigating glutamine kinetics in humans.Therapeutic benefits of glutamine: An umbrella review of meta-analyses.Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury.Tumor necrosis factor-α suppresses the protein fractional synthesis rate of the small intestine stimulated by glutamine in rats.Plasma glutamine concentration after intensive care unit discharge: an observational study.Development and current use of parenteral nutrition in critical care - an opinion paper Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients.Plasma Glutamine Concentrations in Liver Failure.Plasma glutamine levels in patients after non-elective or elective ICU admission: an observational study Glutamine may repress the weak LPS and enhance the strong heat shock induction of monocyte and lymphocyte HSP72 proteins but may not modulate the HSP72 mRNA in patients with sepsis or trauma A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition.The evolution of nutrition in critical care: how much, how soon?Alterations in glutamine metabolism and its conversion to citrulline in sepsis.Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial.Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study.Burn injury differentially alters whole-blood and organ glutathione synthesis rates: An experimental model.Reduced Hsp70 and Glutamine in Pediatric Severe Malaria Anemia: Role of Hemozoin in Suppressing Hsp70 and NF-κB activation.Plasma glutamine levels before cardiac surgery are related to post-surgery infections; an observational study.Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.Parenteral glutamine supplementation in critical illness: a systematic review.Glutamine--from conditionally essential to totally dispensable?Metabolic and nutritional support of critically ill patients: consensus and controversies.Glutamine Supplementation in Intensive Care Patients: A Meta-Analysis of Randomized Clinical Trials.Global and targeted metabolomics of synovial fluid discovers special osteoarthritis metabolites.When Is It Appropriate to Use Glutamine in Critical Illness?Is the glutamine story over?Glutamine supplementation.Should We Increase Protein Delivery During Critical Illness?Glutamine Supplementation in Parenteral Nutrition and Intensive Care Unit Patients: Are We Throwing the Baby Out With the Bathwater?Glutamine in critically ill patients: is it a fundamental nutritional supplement?Uncertainty about the safety of supplemental glutamine: an editorial on "A randomized trial of glutamine and antioxidants in critically ill patients".Glutamine, fish oil and antioxidants in critical illness: MetaPlus trial post hoc safety analysis How to understand the results of studies of glutamine supplementation.Whole blood glutathione status and ICU morbidity in critically ill children.

P2860

Q26767206-834B5013-D2C3-48E7-8EEF-A0C95D3B4382 Q26782662-2D53A50B-C306-49E9-960C-CB00754C22BA Q26797452-4315CF6D-5266-4820-B47F-A1CF59CFF6DD Q33584076-99F52E6F-C42D-4818-B198-588694A57D8F Q33685522-8FC761BA-1820-494C-94ED-8F4A69005270 Q33750288-BB483AE0-D1EB-4AB4-9687-A4B63E273991 Q33754020-1E701E19-2502-4C7B-B587-1E2564A59504 Q34486267-CC08C425-CE40-4A31-9F66-EA1A2EEBFF27 Q34795654-A283898C-AC84-46E0-8DAF-D10ED0372481 Q34990969-489F92F5-AA38-4CCF-96EA-6C117A5EA027 Q35580680-6AA6A921-E0F2-49E6-BB18-FD4481FB2A97 Q35584807-1B780AB1-1212-4CBD-AA62-EBCA5702E1AD Q35902922-DF99BFC1-17E4-4E62-9D25-ACAB464D9E7F Q35944467-BFD89B09-37C5-4579-B18D-6F35CDC7E232 Q35953209-C2A3DD51-0FFB-4AFC-AE90-BD435D036BCA Q36208909-53DC82A6-6C9B-4C72-9C44-A1E8210AC16A Q36443146-CA3FF448-2811-42D1-A011-9E7F882D877E Q36702438-15081985-6212-4877-B87E-233A5D47FFB8 Q36923707-BFE827CC-82BA-4BEB-9462-F618BBF10740 Q36927395-74E7330C-BBDB-4194-9AEC-96FD149C728B Q37144755-CA7FE143-E505-4B92-B812-C8A9804BEDDD Q37161228-6941AB2F-7235-4089-9B79-A4DC9B6295ED Q37370525-0AB44666-A0DE-47D5-A694-81B383400554 Q37440020-7ADA19A8-6E99-4BEE-BD88-12D7C6FD3662 Q37698325-E922E2C7-84BE-4C59-8E15-E6D6CFB5AB3E Q38205494-5FFA6279-ABA5-4C8C-BD9D-9B6367A67759 Q38231810-FEBC389D-82B3-4919-BBD9-F3C6523B3299 Q38426589-944725E6-EC57-49B2-8DD8-03CFA0CD7D32 Q38562404-CA8D6CCB-B705-4105-9B63-FB922D3F2DDE Q38821499-62482A65-9D8B-44F1-B91F-100B3B1788A2 Q38849482-15789712-44E2-424C-A3B4-EACB19EB96C0 Q39200866-E26A954D-AFB6-4C1C-BA26-70D080317BAC Q39386551-B244AD26-9233-4245-837A-B5D33E67D9D1 Q40807702-8CCCD8BA-30F6-4F9D-B814-0F0C42755A9F Q41444401-1CC49AEB-E49E-46C8-941D-5E2138957C48 Q41821248-E869E892-F1A0-4F91-9A2D-34E849750D05 Q42272214-642534DE-9A42-452D-A46F-5F75F24DE144 Q42353607-9952C33C-C0E0-478A-9799-48B812809227 Q42923500-7D49C7F2-15B8-4C1E-BB1A-24A41F3753E1 Q47684911-BA287111-3E91-4901-A077-481A1E8E3914

P2860

Glutamine and glutathione at ICU admission in relation to outcome.

http://www.wikidata.org/entity/Q35804639

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Glutamine and glutathione at ICU admission in relation to outcome.

@ast

Glutamine and glutathione at ICU admission in relation to outcome.

@en

type

label

Glutamine and glutathione at ICU admission in relation to outcome.

@ast

Glutamine and glutathione at ICU admission in relation to outcome.

@en

prefLabel

Glutamine and glutathione at ICU admission in relation to outcome.

@ast

Glutamine and glutathione at ICU admission in relation to outcome.

@en

P1433

Q35804639-34928A47-90AA-464B-A273-C57ACF8592A9

P1476

Q35804639-B3EBC9BA-4CF1-4907-A5F0-FD7979173830

P2093

Q35804639-0F28D911-033E-4247-87FA-D84044A3508C

Q35804639-3A8700ED-EC9B-4B9E-97DA-77BC17FEB81A

Q35804639-852D34E3-587B-4FED-B9CA-3B1E0D272E0E

Q35804639-B062E4F4-5778-4B1C-A359-8383D2DAD5C2

Q35804639-D67F90DC-EDFF-4335-88FC-C8EB8B523142

P2860

Q35804639-1646A225-7086-4174-9520-3F23FE86FD1F

Q35804639-20663EE3-49CB-4BE9-A3B8-23340DF58DAE

Q35804639-2ACAE577-8463-4533-889B-6F1212D735D8

Q35804639-2BAC7565-E81A-4EE9-BD22-3975EBA17D4C

Q35804639-374A66CB-50A5-4D1C-A6DE-790325F73F18

Q35804639-3BD7887E-D23C-4C9D-9A07-406F5BB62201

Q35804639-502B450D-AEB6-4660-B040-9A825E6795A4

Q35804639-5381D1C5-9E19-4637-A813-CF664BA745BE

Q35804639-851E143E-76E3-45E7-9A56-48557032B483

Q35804639-8998B1C0-66A2-4A30-AE1A-AE4521D7C039

P304

Q35804639-92523412-BFE7-468C-A9CF-9011817F81A8

P31

Q35804639-2113F5E7-86F7-42D6-BFB5-B6F9C33EAFC2

P356

Q35804639-CFA51C93-E6C9-4D3D-AFED-894A3EF591FC

P407

Q35804639-2C0F3600-C653-4FCD-9844-14A695CE99FA

P433

Q35804639-745DDF5B-B4B8-423E-9DAA-2F5924719050

P478

Q35804639-45BDCC87-8A48-4BDE-B59F-2FB4F8216A50

P577

Q35804639-203BA07F-C5EB-4F8E-A8A8-6DA21F71E9FC

P5875

Q35804639-8E1DCC6E-07D6-4830-AB98-0880935F7CBB

P698

Q35804639-49BB1550-FD57-495E-88DD-F4D05AD72674

P932

Q35804639-8E37E9F9-5007-47F9-AA46-C2F8E4A12E60

P356

P1433

Clinical Science

P1476

Glutamine and glutathione at ICU admission in relation to outcome.

@en

P2093

Christina Hebert

http://www.w3.org/2001/XMLSchema#string

Jan Wernerman

http://www.w3.org/2001/XMLSchema#string

Olav Rooyackers

http://www.w3.org/2001/XMLSchema#string

Paul Castillo Rodas

http://www.w3.org/2001/XMLSchema#string

Åke Norberg

http://www.w3.org/2001/XMLSchema#string

P2860

Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation

Glutamine attenuates post-traumatic glutathione depletion in human muscle.

Temporal changes in whole-blood and plasma glutathione in ICU patients with multiple organ failure.

Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?

Splanchnic and leg exchange of amino acids and ammonia in acute liver failure.

Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients.

Plasma glutamine depletion and patient outcome in acute ICU admissions.

Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients.

Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients.

Glutamine to intensive care unit patients.

P304

591-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20110520

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221750482

http://www.w3.org/2001/XMLSchema#string

P698

22248298

http://www.w3.org/2001/XMLSchema#string

P932

3294430

http://www.w3.org/2001/XMLSchema#string